Globus Medical, Inc. (GMED)
After hours:
| Previous Close | 65.10 |
| Open | 65.74 |
| Bid | 54.00 x 2200 |
| Ask | 82.00 x 800 |
| Day's Range | 63.35 - 65.91 |
| 52 Week Range | 57.21 - 84.23 |
| Volume | |
| Avg. Volume | 837,977 |
| Market Cap | 6.587B |
| Beta (5Y Monthly) | 1.10 |
| PE Ratio (TTM) | 35.73 |
| EPS (TTM) | 1.82 |
| Earnings Date | Feb 15, 2022 - Feb 21, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 77.71 |
- Zacks
Globus Medical (GMED) Completes First Cases With Excelsius3D
Globus Medical's (GMED) Excelsius3D, when combined with ExcelsiusGPS, facilitates greater implant placement accuracy, lowers radiation exposure and reduces operative times.
- GlobeNewswire
Globus Medical Announces First Surgeries Using Excelsius3D™
Intraoperative 3D Imaging System Advances Robotic Navigation Spine SurgeryAUDUBON, Pa., May 18, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today the first surgeries performed with the Excelsius3D™, an intelligent, intraoperative 3-in-1 imaging platform, the latest addition to Globus Medical’s Excelsius™ Ecosystem. Paul C. McAfee, MD, MBA and Mesfin A. Lemma, MD at MedStar Union Memorial Hospital, Roland Kent, MD at Northwest
- Zacks
Globus Medical (GMED) Q1 Earnings Miss Estimates, Margins Dip
According to Globus Medical (GMED), its Q1 results reflect modest revenue growth against a difficult prior-year comparison, coupled with COVID-related revenue impacts in key countries.
